59
Views
12
CrossRef citations to date
0
Altmetric
Article

Colorectal proliferation and apoptosis in serrated versus conventional adenoma‐carcinoma pathway: growth, progression and survival

&
Pages 1241-1248 | Received 07 Jul 2003, Accepted 18 Sep 2003, Published online: 08 Jul 2009

References

  • Potter JD. Colorectal cancer: molecules and populations. JNatl Cancer Inst 1999;91:916–32.
  • George SM, Mäkinen MJ, Jernvall P, Mäkelä J, Vihko P, Karttunen TJ. Cancer classification of advanced colorectal carcinomas by tumor edge morphology: evidence for different pathogenesis and significance of polypoid and nonpolypoid tumors. Cancer 2000;89:1901–9.
  • Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 1990;14:524–37.
  • Michael-Robinson JM, Reid LE, Purdie DM, Biemer-Huttmann AE, Walsh MD, Pandeya N, et al. Proliferation, apoptosis and survival in high-level microsatellite instability sporadic colorectal cancer. Clin Cancer Res 2001;7:2347–56.
  • Guo M, Hay BA. Cell proliferation and apoptosis. Curr Opin Cell Biol 1999;11:745–52.
  • Correa P, Miller MJ. Carcinogenesis, apoptosis and cell proliferation. Br Med Bull 1998;54:154–62.
  • Wong NA, Mayer NJ, MacKell S, Gilmour HM, Harrison DJ. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia. Histopathology 2000;37: 108–14.
  • Soini Y, Virkajärvi N, Lehto VP, Pääkkö P. Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br J Cancer 1996;73:1025–30.
  • Jass JR. Serrated route to colorectal cancer: back street or super highway? J Pathol 2001;193:283–5.
  • Jass JR. Serrated adenoma and colorectal cancer. J Pathol 1999; 187:499–502.
  • Jass JR, Young J, Leggett BA. Evolution of colorectal cancer: change of pace and change of direction. J Gastroenterol Hepatol 2002;17:17–26.
  • Mäkinen MJ, George SMC, Jernvall P, Mäkelä J, Vihko P, Karttunen TJ. Colorectal carcinoma associated with serrated adenoma: prevalence, histological features, and prognosis. J Pathol 2001;193:286–94.
  • Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, et al. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 2001;159:2107–16.
  • Saarnio J, Parkkila S, Parkkila AK, Haukipuro K, Pastorekova S, Pastorek J, et al. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol 1998;153:279–85.
  • Mäkinen JM, Mäkinen MJ, Karttunen TJ. Serrated adenocarcinoma of the rectum associated with perianal Paget’s disease: a case report. Histopathology 2002;41:177–9.
  • Yamauchi T, Watanabe M, Hasegawa H, Yamamoto S, Endo T, Kabeshima Y, et al. Serrated adenoma developing into advanced colon cancer in 2 years. J Gastroenterol 2002;37:467–70.
  • Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 2000;95:3053–63.
  • Leggett BA, Devereaux B, Biden K, Searle J, Young J, Jass J. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol 2001;25:177–84.
  • Tateyama H, Li W, Takahashi E, Miura Y, Sugiura H, Eimoto T. Apoptosis index and apoptosis-related antigen expression in serrated adenoma of the colorectum: the saw-toothed structure may be related to inhibition ofapoptosis. Am J Surg Pathol 2002; 26:249–56.
  • Jass JR, Whitehall VL, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology 2002;123:862–76.
  • Hofstad B, Vatn MH, Andersen SN, Huitfeldt HS, Rognum T, Larsen S, et al. Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years. Gut 1996;39:449–56.
  • Hoff G, Larsen S. Epidemiology of polyps in the rectum and sigmoid colon. Discriminant analysis for identification of individuals at risk of developing colorectal neoplasia. Scand J Gastroenterol 1986;21:848–52.
  • Flohil CC, Janssen PA, Bosman FT. Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon. J Pathol 1996;178: 393–7.
  • Walker JA, Quirke P. Viewing apoptosis through a ‘TUNEL’. J Pathol. 2001;195:275–6.
  • Baretton GB, Diebold J, Christoforis G, Vogt M, Muller C, Dopfer K, et al. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer 1996;77:255–64.
  • Palmqvist R, Rutegard JN, Bozoky B, Landberg G, Stenling R. Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am J Pathol 2000;157: 1947–53.
  • Siitonen SM, Isola JJ, Rantala IS, Helin HJ. Intratumor variation in cell proliferation in breast carcinoma as determined by antiproliferating cell nuclear antigen monoclonal antibody and automated image analysis. Am J Clin Pathol 1993;99:226–31.
  • Piffko J, Bankfalvi A, Ofner D, Kusch F, Bocker W, Joos U, et al. In situ assessment of cell proliferation at the invasive margin of oral squamous cell carcinomas. Virchows Arch 1996;429:229–34.
  • Agui T, McConkey DJ, Tanigawa N. Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas. Anticancer Res 2002;22:1769–76.
  • Brusselmans K, Bono F, Maxwell P, Dor Y, Dewerchin M, Collen D, et al. Hypoxia-inducible factor-2alpha (HIF-2alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia. J Biol Chem 2001;276:39192–6. Epub 2001 Aug 23.
  • Bauer KD, Lincoln ST, Vera-Roman JM, Wallemark CB, Chmiel JS, Madurski ML, et al. Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinomas. Lab Invest 1987;57:329–35.
  • Harlow SP, Eriksen BL, Poggensee L, Chmiel JS, Scarpelli DG, Murad T, et al. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas. Cancer Res 1991;51:2403–9.
  • Palmqvist R, Oberg A, Bergstrom C, Rutegard JN, Zackrisson B, Stenling R. Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer. Br J Cancer 1998;77: 917–25.
  • Bryne M, Boysen M, Alfsen CG, Abeler VM, Sudbo J, Nesland JM, et al. The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Res 1998;18:4757–64.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.